Laboratory Corp (NYSE: LH) Boosts Efficiency with InstantGMP's Innovative LIMS Launch
- InstantGMP launched a new LIMS that integrates with its manufacturing platform for enhanced laboratory operations and efficiency.
- The LIMS features Master Test Protocols and Active Test Protocols, ensuring compliance and reducing operational errors.
- InstantGMP's solution is a cost-effective alternative to traditional LIMS, optimizing processes and supporting regulatory adherence.
Innovative LIMS Launch Enhances Laboratory Operations for InstantGMP
InstantGMP™, headquartered in Cary, North Carolina, has introduced a new Laboratory Information Management System (LIMS) that integrates effectively with its existing manufacturing platform, InstantGMP PRO. This development marks a significant advancement in laboratory operations, aiming to unify processes across laboratory, production, and inventory management. Dr. Richard Soltero, President of InstantGMP, emphasizes that traditional LIMS often function in isolation, resulting in costly integrations and manual data entry. By contrast, InstantGMP’s LIMS offers a cohesive solution that provides real-time updates on material statuses, enhancing workflow efficiency and regulatory compliance.
The LIMS employs a two-tier protocol structure that includes Master Test Protocols (MTPs) for standardized methods and Active Test Protocols (ATPs) for live testing. This framework not only facilitates version control but also ensures compliance through comprehensive digital audit trails. The system supports varied test result types—both quantitative and qualitative—and automatically generates Certificates of Analysis (COAs) with digital signatures. This feature is pivotal in minimizing errors and enhancing overall operational efficiency, a critical need in the highly regulated pharmaceutical, supplement, and biotech industries. By dynamically linking MTPs to product specifications, the LIMS ensures the use of current testing methods, reducing the risk associated with outdated practices.
With this integration, InstantGMP positions itself as a cost-effective alternative to traditional standalone LIMS systems. The forward-thinking design optimizes processes and reduces total ownership costs for its users, which is particularly beneficial in an industry that demands both efficiency and compliance. By bridging the gap between laboratory operations and inventory management, InstantGMP's LIMS represents a significant step forward in laboratory technology, supporting organizations in their quest for improved operational efficiency and regulatory adherence.
In related developments, Illume Fertility, a notable fertility practice, showcases its commitment to reproductive innovation by presenting significant studies at the American Society for Reproductive Medicine (ASRM) Scientific Congress. These studies underline advancements in laboratory processes, highlighting the importance of evidence-based research in enhancing patient outcomes in the fertility sector.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

